Accuray Inc.

379 articles with Accuray Inc.

• Hong Kong Sanatorium & Hospital Signs Agreement at ESTRO to Acquire the Synchrony® Motion Tracking and Correction Technology for the Accuray Radixact® System

  5/1/2019

  Hospital is the First in Asia to Procure Synchrony for Radixact, Furthering Its Goal to Use Advanced Medical Technology to Improve Cancer Treatments

• Accuray Launches Synchrony® Motion Tracking and Correction Technology for the Radixact® System

  4/24/2019

  Only Radiotherapy System with Helical Delivery Capability and Intrafraction Motion Synchronization Functionality, Offering Expanded Versatility and Increased Precision in the Treatment of Simple to Complex Tumors

• Accuray Reports Fiscal 2019 Third Quarter Results

  4/23/2019

  Accuray Incorporated reported its financial results for the third quarter of fiscal 2019 ended March 31, 2019.

• Phase 3 Randomized Trial Data Shows SBRT has Similar Acute Safety Profile to Conventional Radiation Therapy in Patients with Localized Prostate Cancer

  2/22/2019

  Data Presented at the 2019 Genitourinary Cancers Symposium Reinforces Benefits of Short Course of Treatment Using Stereotactic Body Radiation Therapy for Low- or Intermediate-Risk Prostate Cancer

• Accuray Reports Fiscal 2019 Second Quarter Results

  1/22/2019

  Accuray Inc. (NASDAQ: ARAY) today reported its financial results for the second quarter of fiscal 2019 ended December 31, 2018.

• The Urology Group Surpasses 1,600 Prostate Cancer Patients Treated with the Accuray CyberKnife® M6™ System

  1/17/2019

  According to the American Cancer Society, prostate cancer is the most common cancer in American men other than skin cancer.

• Accuray To Report Fiscal 2019 Second Quarter Financial Results on January 22, 2019

  1/8/2019

  Management will host a conference call to review the results at 1:30 p.m. PT/4:30 p.m. ET on the same day.

• Accuray to Present at the 37th Annual J.P. Morgan Healthcare Conference on January 9, 2019

  1/2/2019

  Accuray Incorporated announced today that the Company will present at the J.P. Morgan 37th Annual Healthcare Conference on Wednesday, January 9, 2019 at the Westin St. Francis Hotel in San Francisco. Attendance at the conference is by invitation only.

• Accuray Appoints Shig Hamamatsu Chief Financial Officer

  11/19/2018

  Accuray Incorporated (NASDAQ: ARAY) announced today that its Board of Directors has named Shig Hamamatsu as senior vice president, chief financial officer effective immediately.

• Accuray Showcases Radiation Therapy Innovations Designed to Improve What's Possible for Patients at ASTRO 2018

  10/17/2018

  Meeting attendees can visit Accuray at booth #2511 on October 21 - 23, 2018 in San Antonio, Texas

• Accuray To Report Fiscal 2019 First Quarter Financial Results On October 30, 2018

  10/11/2018

  Management will host a conference call to review the first quarter results at 1:30 p.m. PT/4:30 p.m. ET on October 30, 2018.

• Technische Universität München Hospital is First in Germany to Treat Cancer Patients with Accuray Radixact® System

  10/9/2018

  Versatile, Easy-to-Use System Offers Patients Access to Technologically Advanced Cancer Care

• HCG is First in India to Treat Cancer Patients Using the Accuray Radixact® System

  10/4/2018

  Adoption of Innovative Radiation Therapy Technology Reinforces South Asian Cancer Center's Position as Pioneer in Patient Care

• Addenbrooke's Hospital is First in the UK to Treat Cancer Patients with Accuray Radixact® System

  7/25/2018

  Internationally Renowned Centre in Cambridge, England is First NHS Hospital to Install the Innovative Radiation Therapy System

• Accuray To Report Fiscal 2018 Fourth Quarter And Full Year Financial Results On August 16, 2018

  7/19/2018

  Accuray Incorporated will report results for its fourth quarter and fiscal year 2018 ended June 30, 2018 on Thursday, August 16, 2018 after the market close.

• Joseph E. Whitters Appointed to Accuray Board of Directors

  7/19/2018

  Accuray Inc.(NASDAQ: ARAY) announced today the appointment of Joseph E. Whitters to the company's Board of Directors, effective as of July 16, 2018. In addition, he will serve on the Board's Audit Committee. With Mr. Whitters' appointment, the Accuray Board has been expanded to eight members.

• Fry Construction Completes First Accuray CyberKnife Procedure Room at VA Dallas

  6/12/2018

  The Accuray CyberKnife® System empowers clinicians to make the most of their skills in treating cancer.

• New Studies Show the Accuray TomoTherapy® System Provides Greater Precision, Excellent Clinical Outcomes in Patients Undergoing Total Body Irradiation

  5/30/2018

  Accuray Incorporated (NASDAQ: ARAY) announced today that recently published data from two new studies demonstrate the benefits of the TomoTherapy® System in the delivery of total body irradiation (TBI), a procedure commonly used to prepare patients being treated for leukemia and multiple myeloma for a bone marrow transplant. TBI involves irradiation of the entire body, elevating the need for precision, accuracy and homogeneity in radiation dose delivery

• Accuray Unveils New Company Website Reflecting Industry-Leading Patient-First Cancer Treatment Innovation and Care

  5/15/2018

  Check out the new site at www.accuray.com.

• Accuray Reports Third Fiscal Quarter Results

  4/30/2018

  Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the third fiscal quarter ended March 31, 2018.